Pfizer's Paxlovid Sees China医保 Price Reduced from RMB 2300 to RMB 1890 per Box

The reporter Xu Hong of the Science and Technology Innovation Board learned on the 28th that the medical insurance payment price for Pfizer's star oral anti-COVID drug, Nirmatrelvir Tablets/Ritonavir Tablets combination pack (namely Paxlovid), has been reduced from 2,300 yuan per box to 1,890 yuan per box. Paxlovid was approved for marketing in China this February and was previously temporarily included in medical insurance at a price of 2,300 yuan per box, which is lower than its pricing in the United States.

Open a stock trading account to enjoy benefits, deposit to win a 188 RMB red envelope, 100% chance of winning!

A Wealth of Information, Accurate Interpretation – All on the Sina Finance App

Editor: Liu Wanli SF014